You may have access to the free features available through My Research. You can save searches, save documents, create alerts and more. Please log in through your library or institution to check if you have access.
If you log in through your library or institution you might have access to this article in multiple languages.
Styles include MLA, APA, Chicago and many more. This feature may be available for free if you log in through your library or institution.
You may have access to it for free by logging in through your library or institution.
You may have access to different export options including Google Drive and Microsoft OneDrive and citation management tools like RefWorks and EasyBib. Try logging in through your library or institution to get access to these tools.
In recent years, the incidence rate of nonalcoholic fatty liver disease ( NAFLD) keeps increasing, and the age of onset tends to become younger. NAFLD has become one of the major public health problems in the 21 st century. This article reviews the research advances in the association between some chemokines ( CCL2, CCL5, CXCL8, and CXCL10) and NAFLD in recent years, in order to provide directions for the research on the pathogenesis and prevention and treatment of NAFLD.
